Page last updated: 2024-09-04

mdl 74156 and Liver Dysfunction

mdl 74156 has been researched along with Liver Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dimmitt, DC; Hahne, WF; Martin, LA; Pready, N; Stubbs, K	1

Other Studies

1 other study(ies) available for mdl 74156 and Liver Dysfunction

Article	Year
Pharmacokinetics of dolasetron after oral and intravenous administration of dolasetron mesylate in healthy volunteers and patients with hepatic dysfunction. Journal of clinical pharmacology, 1997, Volume: 37, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Indoles; Injections, Intravenous; Isoenzymes; Liver Diseases; Male; Middle Aged; Quinolizines; Serotonin Antagonists	1997

Article

Year

Pharmacokinetics of dolasetron after oral and intravenous administration of dolasetron mesylate in healthy volunteers and patients with hepatic dysfunction.

Journal of clinical pharmacology, 1997, Volume: 37, Issue:10

Topics: Administration, Oral; Adolescent; Adult; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Indoles; Injections, Intravenous; Isoenzymes; Liver Diseases; Male; Middle Aged; Quinolizines; Serotonin Antagonists

1997